Intraocular lymphatics in ciliary body melanomas with extraocular extension: Functional for lymphatic spread?

Archives of Ophthalmology

Volumn 128, Issue 8, 2010, Pages 1001-1008

  Heindl, Ludwig M ^a   Hofmann, Tanja N ^a   Schrödl, Falk ^b   Holbach, Leonard M ^a   Kruse, Friedrich E ^a   Cursiefen, Claus ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MELAN A; PODOPLANIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CILIARY BODY TUMOR; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPHATIC DRAINAGE; MALE; MELANOMA; PRIORITY JOURNAL; RISK FACTOR;

AGED; ANTIGENS, NEOPLASM; CILIARY BODY; EYE ENUCLEATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MELANOMA; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS; VESICULAR TRANSPORT PROTEINS;

EID: 77955446884     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.143     Document Type: Article

References (37)

1. Coupland SE, Campbell I, Damato B. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability. Ophthalmology. 2008; 115(10):1778-1785.
2. Pach JM, Robertson DM, Taney BS, Martin JA, Campbell RJ, O'Brien PC. Prognostic factors in choroidal and ciliary body melanomas with extrascleral extension. Am J Ophthalmol. 1986;101(3):325-331. (Pubitemid 16132660)
3. Kivelä T, Harbour JW, Coupland SE, et al. Malignant melanoma of the uvea. In: Edge SE, Byrd DR, Carducci MA, Compton CA, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer Publishing Co Inc; 2009.
4. Kujala E, Kivelä T. Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma: evaluation of the 6th edition and future directions. Ophthalmology. 2005;112(6):1135-1144. (Pubitemid 40797473)
5. Dithmar S, Diaz CE, Grossniklaus HE. Intraocular melanoma spread to regional lymph nodes: report of two cases. Retina. 2000;20(1):76-79.
6. Tojo D, Wenig BL, Resnick KI. Incidence of cervical metastasis from uveal melanoma: implications for treatment. Head Neck. 1995;17(2):137-139.
7. Pepper MS. Lymphangiogenesis and tumor metastasis:myth or reality? Clin Cancer Res. 2001;7(3):462-468.
8. Clarijs R, Ruiter DJ, deWaal RM. Lymphangiogenesis in malignant tumours: does it occur? J Pathol. 2001;193(2):143-146.
9. Beasley NJ, Prevo R, Banerji S, et al. Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 2002;62(5):1315- 1320.
10. Kyzas PA, Geleff S, Batistatou A, Agnantis NJ, Stefanou D. Evidence for lymphangiogenesis and its prognostic implications in head and neck squamous cell carcinoma. J Pathol. 2005;206(2):170-177. (Pubitemid 40754020)
11. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer. 2002;2(8):573-583.
12. Dadras SS, Paul T, Bertoncini J, et al. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol. 2003;162(6):1951-1960.
13. Streit M, Detmar M. Angiogenesis, lymphangiogenesis, and melanoma metastasis. Oncogene. 2003;22(20):3172-3179.
14. Maula SM, Luukkaa M, Grénman R, Jackson D, Jalkanen S, Ristamäki R. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res. 2003;63(8): 1920-1926. (Pubitemid 36460859)
15. Urabe A, Matsumoto T, Kimura M, Sonoue H, Kinoshita K. Grading system of lymphatic invasion according to D2-40 immunostaining is useful for the prediction of nodal metastasis in squamous cell carcinoma of the uterine cervix. Histopathology. 2006;49(5):493-497.
16. Zimmermann P, Dietrich T, Bock F, et al. Tumour-associated lymphangiogenesis in conjunctival malignant melanoma. Br J Ophthalmol. 2009;93(11):1529-1534.
17. Karkkainen MJ, Petrova TV. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene. 2000;19(49): 5598-5605.
18. Schoppmann SF, Birner P, Stöckl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002;161(3):947-956.
19. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113(7):1040-1050.
20. Maruyama K, Ii M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest. 2005; 115(9):2363-2372.
21. Padera TP, Kadambi A, di Tomaso E, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 2002;296(5574):1883-1886. (Pubitemid 34596277)
22. Cursiefen C, Kruse FE, Naumann GOH. Cornea and limbus. In: Naumann GOH, Holbach L, Kruse FE, eds. Applied Pathology for Ophthalmic Microsurgeons. Berlin, Germany: Springer-Verlag; 2008:97-130.
23. Streilein JW, Yamada J, Dana MR, Ksander BR. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts. Transplant Proc. 1999;31(3):1472-1475.
24. Clarijs R, Schalkwijk L, Ruiter DJ, de Waal RM. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42(7):1422-1428.
25. Heindl LM, Hofmann TN, Knorr HL, et al. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Invest Ophthalmol Vis Sci. 2009;50(5):1988-1995.
26. Heindl LM, Hofmann TN, Adler W, et al. Intraocular tumor-associated lymphangiogenesis: a novel prognostic factor for ciliary body melanomas with extraocular extension? Ophthalmology. 2010;117(2):334-342.
27. Banerji S, Ni J, Wang SX, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol. 1999;144(4): 789-801. (Pubitemid 29234556)
28. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol. 1999;154(2):385-394.
29. Cursiefen C, Schlötzer-Schrehardt U, Küchle M, et al. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci. 2002;43(7):2127-2135.
30. Jackson DG. New molecular markers for the study of tumour lymphangiogenesis. Anticancer Res. 2001;21(6B):4279-4283. (Pubitemid 34240959)
31. Jungbluth AA, Busam KJ, Gerald WL, et al. A103: an anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol. 1998;22(5):595-602.
32. Schroedl F, Brehmer A, Neuhuber W, Kruse FE, May CA, Cursiefen C. The normal human choroid is endowed with a significant number of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1)-positive macrophages. Invest Ophthalmol Vis Sci. 2008;49(12):5222-5229.
33. Yücel YH, Johnston MG, Ly T, et al. Identification of lymphatics in the ciliary body of the human eye: a novel "uveolymphatic" outflow pathway. Exp Eye Res. 2009; 89(5):810-819.
34. Bock F, Onderka J, Dietrich T, et al. Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci. 2007;48(6):2545-2552.
35. Cursiefen C, Bock F, Horn FK, et al. GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. Ophthalmology. 2009;116(9):1630-1637.
36. Bock F, Onderka J, Dietrich T, Bachmann B, Pytowski B, Cursiefen C. Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation. Graefes Arch Clin Exp Ophthalmol. 2008;246(1):115-119.
37. Dietrich T, Onderka J, Bock F, et al. Inhibition of inflammatory lymphangiogenesis by integrin α5 blockade. Am J Pathol. 2007;171(1):361-372. (Pubitemid 47339252)